Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New approaches for precise response evaluation in hepatocellular carcinoma Hayano K; Fuentes-Orrego JM; Sahani DVWorld J Gastroenterol 2014[Mar]; 20 (12): 3059-68With the increasing clinical use of cytostatic and novel biologic targeted agents, conventional morphologic tumor burden assessments, including World Health Organization criteria and Response Evaluation Criteria in Solid Tumors, are confronting limitations because of their difficulties in distinguishing viable tumor from necrotic or fibrotic tissue. Therefore, the investigation for reliable quantitative biomarkers of therapeutic response such as metabolic imaging or functional imaging has been desired. In this review, we will discuss the conventional and new approaches to assess tumor burden. Since targeted therapy or locoregional therapies can induce biological changes much earlier than morphological changes, these functional tumor burden analyses are very promising. However, some of them have not gone thorough all steps for standardization and validation. Nevertheless, these new techniques and criteria will play an important role in the cancer management, and provide each patient more tailored therapy.|Biomarkers/metabolism[MESH]|Carcinoma, Hepatocellular/*diagnosis/diagnostic imaging/pathology/therapy[MESH]|Cell Survival[MESH]|Contrast Media[MESH]|Diffusion Magnetic Resonance Imaging[MESH]|Fibrosis/pathology[MESH]|Humans[MESH]|Liver Neoplasms/*diagnosis/diagnostic imaging/pathology/therapy[MESH]|Liver/pathology[MESH]|Magnetic Resonance Imaging[MESH]|Medical Oncology/*methods/standards[MESH]|Necrosis/pathology[MESH]|Perfusion[MESH]|Positron-Emission Tomography[MESH]|Software[MESH]|Treatment Outcome[MESH]|Tumor Burden[MESH] |